Prescient Therapeutics LimitedASX: PTX

FDA Allows PTX IND for Leukemia Phase Ib & II Trials

· Issued by Prescient Therapeutics Limited

Filed with ASX ·

On 6ix: 6ix.com/news/fda-allows-ptx-ind-for-leukemia-phase-ib-and-ii-trials

Prescient Therapeutics Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Prescient Therapeutics Limited on 6ix